Results 331 to 340 of about 296,469 (371)

Extending our confidence in sustained virological response

Liver International, 2016
See Article on Page ...
Maan, Raoel, van der Meer, Adriaan
openaire   +3 more sources

Hepatitis C reinfection after sustained virological response

Journal of Hepatology, 2016
On-going risk behaviour can lead to hepatitis C virus (HCV) reinfection following successful treatment. We aimed to assess the incidence of persistent HCV reinfection in a population of people who inject drugs (PWID) who had achieved sustained virological response (SVR) seven years earlier.In 2004-2006 we conducted a multicentre treatment trial ...
Håvard, Midgard, Benedikte, Bjøro, Arild, Mæland, Zbigniew, Konopski, Hege, Kileng, Jan K, Damås, Jørn, Paulsen, Lars, Heggelund, Per K, Sandvei, Jetmund O, Ringstad, Lars N, Karlsen, Kathrine, Stene-Johansen, John H-O, Pettersson, Dagny H, Dorenberg, Olav, Dalgard   +14 more
openaire   +2 more sources

What Are the Benefits of a Sustained Virologic Response to Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection?

Gastroenterology, 2019
Direct-acting antiviral (DAA) regimens are safe and effective at eradicating hepatitis C virus (HCV) infection. Unfortunately, DAAs remain expensive, so treatment of all HCV-infected patients would substantially affect health care costs.
G. Ioannou, J. Feld
semanticscholar   +1 more source

Sustained virologic response by direct‐acting antivirals suppresses skeletal muscle loss in hepatitis C virus infection

Journal of Gastroenterology and Hepatology, 2020
Although chronic liver disease is associated with secondary sarcopenia, the effect of primary disease treatment (hepatitis C virus elimination) on the skeletal muscle is unclear.
K. Endo, Takuro Sato, Akiko Suzuki, Y. Yoshida, Keisuke Kakisaka, A. Miyasaka, Y. Takikawa   +6 more
semanticscholar   +1 more source

Incidence and risk factors of hepatocellular carcinoma change over time in patients with hepatitis C virus infection who achieved sustained virologic response

Hepatology Research, 2019
In patients with chronic hepatitis C, hepatocellular carcinoma (HCC) occurs at a certain frequency, even if a sustained virologic response (SVR) is achieved by antiviral treatment.
Ryoko Yamada, N. Hiramatsu, T. Oze, Ayako Urabe, Yuki Tahata, Naoki Morishita, T. Kodama, Hayato Hikita, R. Sakamori, T. Yakushijin, A. Yamada, H. Hagiwara, E. Mita, M. Oshita, Toshifumi Itoh, H. Fukui, Y. Inui, T. Hijioka, Masami Inada, K. Katayama, S. Tamura, A. Inoue, Y. Imai, T. Tatsumi, T. Hamasaki, N. Hayashi, T. Takehara   +26 more
semanticscholar   +1 more source

Serum sphingolipids predict de novo hepatocellular carcinoma in hepatitis C cirrhotic patients with sustained virologic response

Liver international (Print), 2019
Curing hepatitis C virus (HCV) infection reduces the risk of hepatocellular carcinoma (HCC) development, yet HCC occurs despite sustained virologic response (SVR) in 2%‐8% of cirrhotic patients.
V. Mücke, Dominique Thomas, M. Mücke, O. Waidmann, S. Zeuzem, C. Sarrazin, J. Pfeilschifter, J. Vermehren, F. Finkelmeier, G. Grammatikos   +9 more
semanticscholar   +1 more source

Wisteria floribunda agglutinin‐positive Mac‐2 binding protein predicts early occurrence of hepatocellular carcinoma after sustained virologic response by direct‐acting antivirals for hepatitis C virus

Hepatology Research, 2018
The aim of this study is to clarify the value of serum Wisteria floribunda agglutinin‐positive Mac‐2 binding protein (WFA+‐M2BP) for predicting hepatocellular carcinoma (HCC) in chronic hepatitis C patients who achieved sustained virologic response (SVR)
Y. Yasui, M. Kurosaki, Y. Komiyama, Hitomi Takada, N. Tamaki, Keiya Watakabe, M. Okada, Wann Wang, Takao Shimizu, Y. Kubota, M. Higuchi, K. Takaura, K. Tsuchiya, H. Nakanishi, Yuka Takahashi, J. Itakura, N. Enomoto, N. Izumi   +17 more
semanticscholar   +1 more source

Early identification of achieving a sustained virological response in chronic hepatitis C patients without a rapid virological response

Journal of Gastroenterology and Hepatology, 2010
AbstractBackground and Aim:  A number of hepatitis C virus (HCV) patients without a rapid virological response (RVR) achieved a sustained virological response (SVR) with peginterferon‐α‐2a/ribavirin. The aim of this study was to identify factors associated with SVR in non‐RVR patients.Methods:  Baseline and on‐treatment factors were used to explore the
Chung-Feng, Huang, Jeng-Fu, Yang, Jee-Fu, Huang, Chia-Yen, Dai, Chang-Fu, Chiu, Nai-Jen, Hou, Ming-Yen, Hsieh, Zu-Yau, Lin, Shinn-Cherng, Chen, Ming-Yuh, Hsieh, Liang-Yen, Wang, Wen-Yu, Chang, Wan-Long, Chuang, Ming-Lung, Yu   +13 more
openaire   +2 more sources

Predictive value of rapid virological response and early virological response on sustained virological response in HCV patients treated with pegylated interferon α‐2a and ribavirin

Journal of Gastroenterology and Hepatology, 2007
AbstractBackground and Aim:  The therapeutic effect of pegylated interferon (peg‐IFN)‐α‐2a combination with ribavirin on patients with chronic hepatitis C virus (HCV) infection is dependent on the rapidity of the virological response. The aim of this study was to investigate the predictive value of rapid virological response (RVR) and early virological
Jian-Wu, Yu, Gui-Qiang, Wang, Li-Jie, Sun, Xiao-Guang, Li, Shu-Chen, Li   +4 more
openaire   +2 more sources

Sustained Virological Response After Early Discontinuation of Hepatitis C Treatment

Journal of Viral Hepatitis
ABSTRACTTo date, the effectiveness of direct‐acting antivirals (DAAs) discontinued before 4 weeks has not been analysed in routine clinical practice. The study aimed to determine whether such a short therapy will enable achieving a sustained virological response under real‐world experience.
Robert Flisiak, Dorota Zarębska‐Michaluk, Ewa Janczewska, Anna Parfieniuk‐Kowerda, Włodzimierz Mazur, Marek Sitko, Justyna Janocha‐Litwin, Rafał Krygier, Beata Lorenc, Anna Piekarska, Barbara Sobala‐Szczygieł, Krystyna Dobrowolska, Łukasz Socha, Jerzy Jaroszewicz   +13 more
openaire   +3 more sources